查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765375

全球子宫颈发育不良诊断市场

Cervical Dysplasia Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球子宫颈发育不良诊断市场规模将达 8.977 亿美元

全球子宫颈发育不良诊断市场规模预计在2024年为6.378亿美元，到2030年将达到8.977亿美元，在分析期间（2024-2030年）的复合年增长率为5.9%。诊断测试是本报告分析的细分市场之一，预计其复合年增长率为6.0%，到分析期结束时将达到7.938亿美元。诊断设备细分市场在分析期间内的复合年增长率预计为5.1%。

美国市场规模估计为 1.757 亿美元，中国市场预计复合年增长率为 5.4%

美国子宫颈发育不良诊断市场规模预计在2024年达到1.757亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.393亿美元，在2024-2030年的分析期间内，复合年增长率为5.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为5.4%和4.7%。在欧洲，预计德国市场的复合年增长率为4.8%。

全球子宫颈发育不良诊断市场—主要趋势与驱动因素摘要

为什么子宫颈发育不良是医疗保健领域的热门话题？

子宫颈发育不良是一种癌前病变，由子宫颈表面异常细胞生长引起，主要由人类乳突病毒 (HPV) 引起。早期发现子宫颈发育不良对于预防子宫颈癌发展至关重要，因此诊断在女性保健中至关重要。随着人们对子宫颈癌预防意识的增强，诊断对于识别和治疗子宫颈发育不良的重要性也日益凸显。随着筛检计画的普及以及医疗保健系统对预防措施的日益重视，子宫颈抹片检查、HPV 检测和阴道镜检查的使用率显着增加。早期诊断和早期疗育可带来更好的治疗效果，并能减轻全球子宫颈癌的整体负担，尤其是在医疗保健可近性不断改善的地区。

技术进步如何影响子宫颈发育不良的诊断？

技术进步正在重塑子宫颈发育不良诊断的模式。液基细胞学和HPV分子检测等现代筛检技术提高了诊断准确性，使异常细胞能够更早、更准确地被发现。数位阴道镜检查、人工智慧驱动的诊断工具以及病理实验室的自动化进一步提高了诊断准确性，最大限度地减少了人为错误，并缩短了周转时间。远端医疗也备受关注，使偏远地区的患者无需前往专科医疗中心即可获得专家诊断。随着此类技术创新的不断发展，子宫颈发育不良诊断在各种医疗环境中变得更加便利、经济高效且可靠。

是什么推动了子宫颈发育不良诊断需求的增加？

推动子宫颈发育不良诊断需求成长的关键因素有几个。政府不断推出旨在预防子宫颈癌的措施和公共卫生宣传活动，推动了子宫颈癌筛检工作的进行。此外，随着人们对HPV感染风险的认识不断提高，以及疫苗的普及，越来越多的女性开始定期进行子宫颈癌筛检。医疗保健机构正在采用先进的诊断技术，医疗基础设施的不断扩张也使得新兴国家的诊断服务更加便利。此外，HPV相关感染疾病的增加以及女性人口老化加剧，也促使人们对早期检测产生了浓厚的兴趣，从而增加了子宫颈发育不良诊断解决方案的需求。

推动子宫颈发育不良诊断市场成长的关键因素有哪些？

子宫颈发育不良诊断市场的成长受到多种因素的推动，包括筛检项目的增加、诊断技术的进步以及HPV感染率的上升。推广子宫颈癌筛检的公共卫生倡议，例如政府资助的免费或低成本子宫颈抹片检查项目，显着增加了接受检测的女性数量。此外，基于人工智慧的筛检工具和改进的分子诊断方法等技术创新有助于提高检测的准确性和效率，从而推动了市场的成长。此外，发展中地区医疗基础设施的不断扩大以及人们对早期检测在预防子宫颈癌方面重要性的认识不断提高，也是推动市场扩张的主要因素。

部分

最终使用者（医院、诊断中心、私人妇科诊所、研究和学术机构、门诊手术中心）、类型（诊断测试、诊断设备）

受访公司范例

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP16261

Global Cervical Dysplasia Diagnostics Market to Reach US$897.7 Million by 2030

The global market for Cervical Dysplasia Diagnostics estimated at US$637.8 Million in the year 2024, is expected to reach US$897.7 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of the analysis period. Growth in the Diagnostic Devices segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$175.7 Million While China is Forecast to Grow at 5.4% CAGR

The Cervical Dysplasia Diagnostics market in the U.S. is estimated at US$175.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$139.3 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Cervical Dysplasia Diagnostics Market - Key Trends & Drivers Summarized

Why Is Cervical Dysplasia Gaining More Attention in Healthcare?

Cervical dysplasia is a precancerous condition where abnormal cell growth occurs on the surface of the cervix, primarily due to the human papillomavirus (HPV). Early detection of cervical dysplasia is crucial in preventing the progression to cervical cancer, making diagnostics essential in women's healthcare. As awareness of cervical cancer prevention increases, so too does the importance of diagnostics for identifying and managing cervical dysplasia. With screening programs becoming more widespread and healthcare systems emphasizing preventive measures, there has been a marked rise in the use of Pap smears, HPV testing, and colposcopies. Early diagnosis and intervention can lead to better outcomes, reducing the overall burden of cervical cancer globally, particularly in regions where healthcare access is improving.

How Are Technological Innovations Impacting Cervical Dysplasia Diagnostics?

Technological advancements are reshaping the landscape of cervical dysplasia diagnostics. Modern screening techniques, such as liquid-based cytology and molecular testing for HPV, have enhanced the accuracy of diagnostic procedures, enabling earlier and more precise detection of abnormal cells. Digital colposcopy, AI-driven diagnostic tools, and automation in pathology laboratories are further enhancing diagnostic precision, minimizing human error, and reducing turnaround times. Telemedicine has also gained prominence, allowing patients in remote areas to receive expert diagnoses without needing to travel to specialized healthcare centers. As these innovations continue to evolve, they are making cervical dysplasia diagnostics more accessible, cost-effective, and reliable across a wide range of healthcare settings.

Which Factors Are Leading to Increased Demand for Cervical Dysplasia Diagnostics?

Several key factors are driving the growing demand for cervical dysplasia diagnostics. Increased government initiatives and public health campaigns aimed at preventing cervical cancer have boosted screening efforts. Furthermore, growing awareness of the risks of HPV infection, combined with the availability of vaccines, has encouraged more women to undergo regular screenings. Healthcare providers are increasingly adopting advanced diagnostic techniques, and the expansion of healthcare infrastructure in developing countries has made diagnostic services more available. Additionally, the rise in the number of HPV-related infections, along with an aging female population, has heightened the focus on early detection, leading to greater demand for cervical dysplasia diagnostic solutions.

What Are The Key Growth Drivers of The Cervical Dysplasia Diagnostics Market?

The growth in the cervical dysplasia diagnostics market is driven by several factors, including increased screening programs, advancements in diagnostic technology, and rising HPV infection rates. Public health initiatives promoting cervical cancer screening, such as government-backed programs offering free or low-cost Pap smears, have substantially increased the number of women being tested. Furthermore, innovations like AI-based screening tools and improved molecular diagnostics have contributed to more accurate and efficient detection, driving market growth. Additionally, the expanding healthcare infrastructure in developing regions, coupled with growing awareness about the importance of early detection in preventing cervical cancer, has been a significant driver of market expansion.

SCOPE OF STUDY:

The report analyzes the Cervical Dysplasia Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Diagnostic Centers, Private Gynecologists Offices, Research & Academic Institutes, Ambulatory Surgical Centers); Type (Diagnostic Tests, Diagnostic Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Cervical Dysplasia Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of HPV Infections Driving Demand
    • Rising Awareness of Cervical Cancer Screening Programs
    • Advancements in Molecular Diagnostics for Early Detection
    • Growing Adoption of Liquid-Based Cytology for Screening
    • Technological Innovations in HPV DNA Testing
    • Increased Focus on Preventive Healthcare in Developed Markets
    • Integration of AI and Machine Learning in Diagnostic Tools
    • Demand for Point-of-Care Diagnostics in Low-Resource Settings
    • Government Initiatives Promoting Regular Cervical Screening
    • Growing Use of Biomarkers in Cervical Dysplasia Detection
    • Expansion of Diagnostic Services in Emerging Economies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cervical Dysplasia Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cervical Dysplasia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cervical Dysplasia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Private Gynecologists' Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Private Gynecologists' Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Private Gynecologists' Offices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cervical Dysplasia Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION